infertility (assisted reproductive technology)
Women's health · 2014–2016
3decisions
2medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| triptorelin acetate Down-regulation and prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) as part of an… | Mar 2016 | Recommended with restriction | none received |
| follitropin alfa and lutropin alfa Stimulation of follicular development in women with severe LH and FSH deficiency for assisted reproductive technology (IVF/GIFT) treatment. | Mar 2015 | Recommended | input received |
| follitropin alfa and lutropin alfa Treatment of women with severe luteinising hormone (LH) deficiency who are receiving assisted reproductive technology (IVF/GIFT) treatment and require… | Mar 2014 | Not recommended | unclear |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 3 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.